This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Flashing Insider-Buying Alerts

Stocks in this article: ECLMWWRCLLGNDHOGSATSGQNSTMHGC

Ligand Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

One name in the biotechnology and drugs sector where insiders have been very active in is Ligand Pharmaceuticals (LGND). This is a biotechnology company that focuses on drug discovery and early-stage development of pharmaceuticals that address critical unmet medical needs or those that more effective and/or safer than existing therapies. This is a very interesting insider buy since an executive is paying up to own the stock with shares up over 70% so far in 2011.

This company has a market cap of $301 million and an enterprise value of $317 million. This stock trades at a very rich valuation, since their trailing price-to-earnings is 250 and their forward price-to-earnings is 95. Ligand's estimated growth rate for this year is 214% and for next year it's pegged at -78.1%. This company has a bit more debt on their books than cash, since their total cash position is $13.44 million and total debt is $30.11 million.

A director just bought 61,559 shares, or $805,350 worth of stock, between $12.54 and $14.21 per share. This same director has been steadily buying up shares of Ligand in August that now have totaled over $4 million worth of stock.

From a technical standpoint, this is in a very strong uptrend with shares trading well above both its 50-day and 200-day moving averages. This stock has been displaying a very bullish pattern for all of this year with shares making higher highs and higher lows. This shows that large traders have been paying up to buy this stock anytime it has pulled back. The stock also recently broke out above some past resistance at $14.80 a share on big volume.

If you're looking to buy this stock, I would let this name come in a bit since the relative strength index is over 70 which often times marks an overbought reading on any stock. Let this name pullback toward $14 or possible $13.50 a share before you jump in. If it doesn't pullback that much, then you could be a buyer as long as it holds above the key breakout level of $14.80.

5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs